SNBNCBS introduced a No-touch & Painless device for non-invasive screening of bilirubin level expanding Jaundice meter market
As
per the regional assessment, North America is forecast to dominate the global
Jaundice meter market in the near future. This is owing to the high spending on
the healthcare sector coupled with the rapid adoption of the advanced
diagnostic device. According to the U.S. Centers for Medicare & Medicaid
Services, the National health spending is projected to grow at an average
annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028.
There
are a high prevalence and incidence of jaundice around the globe. This is
creating demand for the jaundice monitoring device, thereby fueling the growth
of the Jaundice meter. According to The Regents of The University of
California, Jaundice is a common condition in newborns, affecting 50 percent to
60 percent of full-term babies and 80 percent of those born prematurely. It can
give babies' skin and the whites of their eyes a yellowish tint. Moreover,
advancement in the jaundice monitoring device is again supporting the growth of
the Jaundice
Meter market. For instance, in July 2020, SNBNCBS develops a No-touch &
Painless device for non-invasive screening of bilirubin level in new-born.
A
Jaundice meter is a device that measures the level of jaundice in blood. This
disease is one of the many diseases that can cause harm to one's health as it
is also known as "Jaundice" and is characterized by the yellowing or
discoloration of one's skin, eyes, and other parts of the body. The disease can
also cause damage to the kidneys and other organs of the human body. The main
symptoms of jaundice include an itching sensation or a burning sensation upon
urination. The person may also suffer from nausea, vomiting, fatigue, weight
loss, muscle weakness, joint pains, and problems with the eyes. In some cases,
the person suffering from jaundice may experience a yellow discoloration on the
skin which can be detected through the measurement of serum albumin levels.
Key Developments:
1. In September 2020, Konica
Minolta, Inc. has partnered with the University of California, San Francisco
(UCSF) Benioff Children’s Hospitals to support an initiative helping newborns
in response to the COVID-19 crisis. The motive of this partnership is to
provide a handheld transcutaneous bilirubin*1 meter to UCSF Newborn
Telemedicine Program enabling remote newborn jaundice*2 assessment and
management
2. In July 2020, Scientists at the
SN Bose National Centre for Basic Sciences, Kolkata, have developed non-contact
and non-invasive spectrometry-based techniques for the measurement of bilirubin
level in newborns to screen for signs of jaundice
Comments
Post a Comment